Meet our Experts at ESMO 2018

October 19, 2018 — October 23, 2018

Munich, Germany

ESMO 2018

LET’S MEET AT ESMO 2018! 

Our valuable therapeutic insight in cancer research, paired with data quality expertise, will make a critical difference to the outcome of your clinical trials.


Schedule some time to meet with IDDI Oncology Experts at ESMO 2018 to discuss your situation and see how we can help you achieve your goals faster!

CLICK HERE TO SCHEDULE A MEETING AT ESMO 2018 

Click here to schedule a meeting!

Click here to schedule a meeting!

MEET IDDI ONCOLOGY EXPERTS

MARC BUYSE, Chief Scientific Officer IDDI

MARC BUYSE, ScD
(Chief Scientific Officer IDDI)

Everardo Saad, MD
(Medical Director IDDI)

SCHEDULE A MEETING WITH MARC OR EVERARDO

Leverage Our Oncology Expertise And Gain Efficiency In Your Oncology Trials​

Coming from a scientific background, IDDI is an oncology CRO led by a highly-skilled biostatistical and clinical team of thought-leaders in cancer research. We develop innovative strategies. Our experts know the importance of keeping up to date with all the latest advances in the field of immunotherapy and oncology medicine. IDDI’s expertise lies in the right choice of endpoints, adequate definition of selection criteria and state-of-the-art statistical planning, analysis and modeling tailored to oncology drug development needs.


WHAT DOES IDDI DO? 

THERAPY-FOCUSED DATA SERVICES CRO PROVIDING BIOSTATISTICAL AND ECLINICAL SERVICES ENSURING CLINICAL DATA READY FOR SUBMISSION

Powered by Atypic ®

IDDI